We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Stress Damages Immune System

By Biotechdaily staff writers
Posted on 21 Dec 2005
Researchers have identified the molecular mechanism that causes the immune system to function less effectively when an individual is under physical or mental stress.

Investigators at the Garvan Institute of Medical Research (Darlinghurst, AU) focused their attention on neuropeptide Y (NPY), a 36–amino acid peptide made by neurons throughout the brain and by other secretory cells of the body. More...
NPY has been associated with a number of physiologic processes in the brain, including the regulation of energy balance, memory and learning, and epilepsy.

The investigators worked with a line of mice that had been genetically engineered to lack the gene for production of NPY. They showed that T cells from NPY-deficient mice were hyper-responsive to activation and triggered severe colitis after transfer into lymphopenic mice. These findings implied that signaling through an NPY receptor on T cells inhibited T cell activation and controlled the magnitude of T cell responses. Strangely enough, the NPY-deficient mice were resistant to T helper type 1 (Th1) cell-mediated inflammatory responses and showed reduced levels of the Th1 cell-promoting cytokine interleukin 12 and reduced interferon gamma production.

This shortcoming was due to functionally impaired antigen-presenting cells (APCs), and consequently, NPY-deficient mice had reduced numbers of effector T cells. These results, which were published in the December 5, 2005, issue of the Journal of Experimental Medicine, demonstrated a fundamental bimodal role for the NPY receptor in the immune system, serving as a strong negative regulator on T cells as well as a key activator of APC function.

Senior author Dr. Fabienne Mackay, associate professor of medicine at the Garvan Institute of Medical Research, said, "Under normal conditions, circulating immune cells produce small amounts of NPY, which enables the immune cells on sentry duty and the TH1 immune cells to operate--it is a yin and yang kind of situation. But too much NPY means that the TH1 attack is prevented despite the foreign invaders being identified--and this is what happens during stress.”



Related Links:
Garvan Institute for Medical Research

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.